Schering Plough
May 5, 2008
Investors Breathe Right With Sepracor
“The acquisition of Oryx fulfills a long-standing corporate objective of developing a commercial footprint in the strategically important Canadian pharmaceutical market”
Investors of Sepracor were breathing easy on Thursday after the company beat the Street on earnings per share and settled a pesky lawsuit, but the quarter wasn't without its hiccups. via Forbes.com
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Vytorin: A Setback For Merck And Schering | Wed | Well of course | 3 |
| New Jersey: Cholesterol pill fails to lower risks | Jul 22 | Hard Boiled Egg | 1 |
| Vytorin | Jul 21 | this just in | 1 |
| Cholesterol drug of no use in study (from Jan '08) | Jul 17 | DKut | 2 |
| Study raises questions on cholesterol drug, makers (from Jan '08) | Jul 17 | WandaM | 4 |
| Study: Cholesterol combination not superior to ... (from Jan '08) | Jul 17 | WandaM | 2 |
| Vytorin Expert Panel Says 'Go Back to Statins' | Jul 16 | WandaM | 2 |
Most Popular
